Psilocybin Therapy Works… But Not Like You Think, with Compass Pathways

If one or two psychedelic sessions can produce measurable improvements in treatment-resistant depression, why does modern psychiatry still rely on daily medication? In this episode of Divergent States, we sit down with Dr. Steve Levine, psychiatrist and Chief Patient Officer at Compass Pathways, to break down their newly released Phase 3 clinical trial results for COMP360 psilocybin therapy. But this isn’t a hype piece. This is a critical look at what the data actually shows—and what people m...